Autophagy as a potential therapeutic target in regulating improper cellular proliferation
Frontiers in Pharmacology · 15.05.2025 · 16
DOI: 10.3389/fphar.2025.1579183 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 15.05.2025. Verfasst von Prashant Kumar und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biosciences and Bioengineering, Indian Institute of Technology Jodhpur, Jodhpur, Rajasthan, India. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 308 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Autophagy is a degradative process that makes rapid turnover of old and impaired proteins and organelles possible. It is highly instigated by stress signals, like starvation, and contributes to the cell’s homeostasis. Autophagy performs a crucial function in keeping cell genomic integrity stable. Impaired autophagic flux is implicated in neurodegenerative diseases, abnormal ageing, and cancerous diseases. In diseases like cancer, autophagy performs a dualistic function; it can have both a tumor-suppressive and supportive role. Autophagy in the initial phases of tumorigenesis maintains the integrity of the genome and, if it fails, leads to cell death, thus having a tumor-suppressive role. Meanwhile, autophagy also imparts the function of the pro-survival mechanism in the latter stages of tumorigenesis and supports the cancerous cells in surviving conditions like hypoxia and increased oxidative stress. Autophagy also helps cancerous cells develop drug resistance in some cases. Thus, modulation of the autophagic mechanism is a possible therapeutic strategy in cancer therapy as its inhibition can sensitise cancer cells to anti-cancerous drugs. The promotion of autophagy, in some cases, can also safeguard cells from toxic protein aggregation and enhanced oxidative stress. Excessive autophagy can result in autophagic cell death. Autophagy also regulates several cellular processes and cell death pathways, like apoptosis. Therefore, an in-depth knowledge of the autophagy process and its regulating molecules is critically important. Pharmaceutical small molecules or cellular target modulation can help modulate the cellular autophagy process in the context of specific disease conditions.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biosciences and Bioengineering, Indian Institute of Technology Jodhpur, Jodhpur, Rajasthan, India.
- Department of Biochemistry, University of Delhi South Campus, New Delhi, India.
- Department of Pharmacy, Birla Institute of Technology and Science Pilani, Pilani, Rajasthan, India.
- Department of Neurochemistry, National Institute of Mental Health and Neuro Sciences, Institute of National Importance, Bangalore, Karnataka, India.
- Institute of Nano Science and Technology, Mohali, Punjab, India.
Zitieren
APA
Kumar, P., Choudhary, A., Kinger, S., Jagtap, Y. A., Prajapati, V. K., Chitkara, D., Chinnathambi, S., Verma, R. K., & Mishra, A. (2025). Autophagy as a potential therapeutic target in regulating improper cellular proliferation. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1579183
Vancouver
Kumar P, Choudhary A, Kinger S, Jagtap YA, Prajapati VK, Chitkara D, et al. Autophagy as a potential therapeutic target in regulating improper cellular proliferation. Frontiers in Pharmacology. 2025;16. doi:10.3389/fphar.2025.1579183
BibTeX
@article{Kumar2025,
author = {Kumar, Prashant and Choudhary, Akash and Kinger, Sumit and Jagtap, Yuvraj Anandrao and Prajapati, Vijay Kumar and Chitkara, Deepak and Chinnathambi, Subashchandrabose and Verma, Rahul Kumar and Mishra, Amit},
title = {Autophagy as a potential therapeutic target in regulating improper cellular proliferation},
journal = {Frontiers in Pharmacology},
year = {2025},
volume = {16},
doi = {10.3389/fphar.2025.1579183}
}
EUVIMED